Edition:
India

People: Zealand Pharma A/S (ZEAL.OQ)

ZEAL.OQ on NASDAQ Stock Exchange Global Select Market

14.00USD
21 Aug 2018
Change (% chg)

$0.33 (+2.41%)
Prev Close
$13.67
Open
$13.92
Day's High
$14.00
Day's Low
$13.92
Volume
123
Avg. Vol
2,673
52-wk High
$20.35
52-wk Low
$12.01

Moeller, Ivan 

Mr. Ivan Moeller has been appointed Senior Vice President, Technical Development & Operations at ZEALAND PHARMA A/S effective as of March 1, 2018. He brings extensive experience from numerous senior management positions in the international pharmaceutical industry, including roles at Novartis in both generics and pharmaceutical manufacturing, as well as strategy, quality assurance, contract manufacturing and supply chain leadership in Germany, the U.S. and Switzerland. Prior to joining Novartis, Ivan Moeller was project leader at The Boston Consulting Group in New York, NY where he led client engagements in the pharmaceutical R&D and manufacturing areas. He started his career at PolyPeptide Laboratories where he was Head of Production site. He holds a Master of Science in Chemical Engineering from the Technical University of Denmark (DTU) and a Master of Business Administration from Harvard Business School.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --